5AAdd image
5-Amino-1MQ
Weight LossSingleAlso known as: 5-Amino-1-methylquinolinium
A small molecule (technically not a peptide) studied as an NNMT inhibitor for metabolic and adipose-tissue applications.
Half-life
—
Common dose
50 – 150 mg
Dosing frequency
Daily
Administration
Oral, Subcutaneous
How it works
5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in adipose tissue of obese individuals. Inhibition preserves NAD+ levels and SAM availability, supporting metabolic flexibility.
Protocol notes
Most commonly oral at 50–150 mg daily. Injectable forms also exist. Cycles of 8–12 weeks.
Reported side effects
Limited human safety data. Reported tolerability is generally good; possible GI upset.